Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply

M. F. W. Gee, E. B. De Vol, H. R. Levy, A. T. Boltyenkov, Sanyal. AJ
Alimentary Pharmacology and Therapeutics · Wiley · 2026-11-03 · DOI: 10.1111/apt.71077

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles